DarioHealth Corp.
DarioHealth Corp. Fundamental Analysis
DarioHealth Corp. (DRIO) shows strong financial fundamentals with a PE ratio of 6.75, profit margin of 2.76%, and ROE of 88.02%. The company generates $0.0B in annual revenue with strong year-over-year growth of 32.86%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 79.5/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze DRIO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentDRIO demonstrates superior asset utilization.
Valuation Score
ExcellentDRIO trades at attractive valuation levels.
Growth Score
ModerateDRIO shows steady but slowing expansion.
Financial Health Score
ExcellentDRIO maintains a strong and stable balance sheet.
Profitability Score
WeakDRIO struggles to sustain strong margins.
Key Financial Metrics
Is DRIO Expensive or Cheap?
P/E Ratio
DRIO trades at 6.75 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, DRIO's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values DarioHealth Corp. at 6.14 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -1.52 times EBITDA. This is generally considered low.
How Well Does DRIO Make Money?
Net Profit Margin
For every $100 in sales, DarioHealth Corp. keeps $2.76 as profit after all expenses.
Operating Margin
Core operations generate -1.64 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $88.02 in profit for every $100 of shareholder equity.
ROA
DarioHealth Corp. generates $56.08 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
DarioHealth Corp. generates limited operating cash flow of $-3.82M, signaling weaker underlying cash strength.
Free Cash Flow
DarioHealth Corp. generates weak or negative free cash flow of $-3.84M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.53 in free cash annually.
FCF Yield
DRIO converts -42.53% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
6.75
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.002
vs 25 benchmark
P/B Ratio
Price to book value ratio
6.14
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.74
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.47
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.73
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.88
vs 25 benchmark
ROA
Return on assets percentage
0.56
vs 25 benchmark
ROCE
Return on capital employed
-0.36
vs 25 benchmark
How DRIO Stacks Against Its Sector Peers
| Metric | DRIO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 6.75 | 28.45 | Better (Cheaper) |
| ROE | 88.02% | 763.00% | Weak |
| Net Margin | 276.11% | -45265.00% (disorted) | Strong |
| Debt/Equity | 0.47 | 0.34 | Weak (High Leverage) |
| Current Ratio | 3.73 | 2795.60 | Strong Liquidity |
| ROA | 56.08% | -16588.00% (disorted) | Strong |
DRIO outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews DarioHealth Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-87.93%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
91.88%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
91.73%
Industry Style: Defensive, Growth, Innovation
High Growth